secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001104659-25-002522
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Carisma Therapeutics receives Nasdaq bid price deficiency notice; has until July 7, 2025 to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice on Jan 6, 2025 for non-compliance with minimum bid price of $1.00 per share.
- Company has 180 days, until July 7, 2025, to regain compliance by having closing bid price ≥$1.00 for 10 consecutive business days.
- If compliance not achieved, may transfer to Nasdaq Capital Market for additional 180-day period, subject to meeting other listing standards.
- Company intends to monitor bid price and consider options including potential reverse stock split if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925002522/0001104659-25-002522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925002522/tm252702d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-002522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer